XBI - IBB: The Stage Is Set For Next Bull Market In Biotechs

As fears of a global pandemic continue to grip stock markets and crude oil, not even the biotechnology sector (IBB) could escape the wrath with IBB declining more than 6% from year-to-date highs. Indeed, although a handful of biotech names such as VIR which are developing vaccines for the Wuhan coronavirus have skyrocketed in recent days, the broader sector ETF has not participated in the hype.

The pharmaceutical industry perhaps has been more focused on the prospect of lower drug costs in an election year. To quote from Barron's:

While the caucuses

Read more ...